This effect extended to non-hypertensive ICH survivors with SBP of 120–129 mmHg and DBP <80 mmHg) who were at increased risk for a composite endpoint of recurrent ICH, small vessel ischaemic stroke, dementia, depression and gait impairment only if they possessed APOE ɛ4. Here, APOE is linked to depressive symptom measurement.